About Bolder Science

Our mission is to provide healthcare professionals with unbiased clinical research information, easily.

Currently, you can access the following clinical trials being conducted worldwide:

359,057 studies
in
219 countries
Clinical trial information and results are updated daily from ClinicalTrials.gov. The latest data update was conducted on 01/20/2021.
This website is for US healthcare professionals

Log In to Bolder Science

or

Don't have an account? Sign Up

Please enter your email address.

You will receive a link to create a new password via email.

Log In

Create an Account

or
(optional) ?

Welcome, !

Please complete the following 4 questions to ensure you receive the information that best suits your needs.

Clinical Trials of Interest

When I’m looking for information on clinical trials, I usually am interested in...

finding clinical trials in which to enroll my patients

Rarely Often

finding newly launched clinical trials (for all phases)

Rarely Often

updates on status changes for clinical trials

Rarely Often

pipeline molecules

Rarely Often

Drug Interventions

Enter up to 3 drug interventions you are currently interested in:

Clinical trial information and results are updated daily from ClinicalTrials.gov. The latest data update was conducted on 01/20/2021.

Does the Understanding of Placebo Mechanisms Compensate for the Loss of Efficacy Associated With Open Label Placebo

Clinicaltrials.gov identifier NCT03934138

Recruitment Status Recruiting

First Posted May 1, 2019

Last update posted May 16, 2019

Study Description

Brief summary:

The investigators are investigating whether, when given detailed information about underlying placebo mechanisms and pain, subjects will have a response similar to that of those subjected to a procedure in which they receive a conventional placebo treatment (associated with deception). STUDY DESIGN: This is a non-inferior parallel, controlled and randomized, single blind trial. POPULATION: The investigators will include in the study 126 subjects without known pathology. Participants will then be divided into 2 groups on a randomized basis. METHODOLOGY: Each subject will undergo three sessions of Cold Pressure Test (CPT), a cold pain stimulation method: calibration, condition of interest (conventional placebo or educated placebo) and control. The investigators' main judgment criterion is be the difference in pain intensity experienced on the visual analog scale between the CPT control and the CPT under the condition of interest. This study will allow the investigators to rule on the non-inferiority of an educated open label placebo compared to a conventional placebo in the context of an acute painful stimulation.

  • Condition or Disease:Acute Pain
  • Intervention/Treatment: Other: Educational movie on placebo mechanisms
    Other: Informative movie on hand washing
  • Phase: N/A
Detailed Description

N/A

Study Design
  • Study Type: Interventional
  • Estimated Enrollment: 126 participants
  • Allocation: Randomized
  • Intervention Model: Parallel Assignment
  • Intervention Model Description: 2 groups : Educated open label placebo And Conventional placebo Each of the subjects will undergo the Cold Pressure text procedure under the condition of interest and a control.
  • Masking: Single (Participant)
  • Primary Purpose: Treatment
  • Official Title: Does the Subject's Understanding of Underlying Placebo Mechanisms Compensate for the Loss of Efficacy Associated With the Disclosure of the Use of a Placebo
  • Actual Study Start Date: May 2019
  • Estimated Primary Completion Date: May 2020
  • Estimated Study Completion Date: September 2020
Arms and interventions
Arm Intervention/treatment
Active Comparator: Educated open label placebo
These subjects will undergo all the same procedures as in the control group. But before the placebo CTP, they will watch a short movie explaining placebo mechanisms. While applying the placebo cream, they will be told that the cream is inert (placebo), efficient to decrease pain caused by cold and the mechanisms seen in the movie will take place.
Other: Educational movie on placebo mechanisms
Educational movie on placebo mechanisms : animated video, duration : 12 minutes. It will be followed by the CPTs : experimentally induced pain by keeping the non dominant hand in cold water (1° Celsius) for a limited time. The duration of immersion is personal and calibrated to be around to ensure that the intensity of pain will be homogeneous (around 7/10 on the visual analogue scale with no treatment)
Placebo Comparator: Conventional placebo
These subjects will watch a video on hand washing. While applying the placebo cream, they will be told that this cream is effective to decreased pain caused by cold.
Other: Informative movie on hand washing
Animated video, duration : 11 minutes. It will be followed by the CPTs : experimentally induced pain by keeping the non dominant hand in cold water (1° Celsius) for a limited time. The duration of immersion is personal and calibrated to be around to ensure that the intensity of pain will be homogeneous (around 7/10 on the visual analogue scale with no treatment).
Outcome Measures
  • Primary Outcome Measures: 1. Pain intensity: Visual Analogue Scale (VAS) [ Time Frame: At the end of the CPT procedure, within 30 seconds after the removal of the hand from the CPT cold water tank. ]
    Evaluated with a Visual Analogue Scale (VAS) from 0 to 100 mm, with a non inferiority margin at 10 mm and a standard deviation at 22 mm.
  • Secondary Outcome Measures: 1. Anxiety respiratory frequency change [ Time Frame: During the CPT procedure ]
    Evaluated thanks to the respiratory frequency collect with a PneumoTrace belt through LabChart software.
  • 2. Anxiety blood pressure change [ Time Frame: During the CPT procedure ]
    Evaluated thanks to the automatic blood pressure monitor (both systolic/diastolic blood pressure, heart rate)
  • 3. Knowledge of placebo's mechanisms [ Time Frame: At the beginning and end of the CPT procedures ]
    Evaluated with a questionnaire made for this study with 17 questions about placebo mechanisms.
  • 4. Perception of the investigator [ Time Frame: At the end of the study, when all CPT procedures have been carried out, within 10 minutes after the last immersion ]
    The perception of the investigator will be evaluated by a visual analogue scale "perception of the investigator".
  • 5. The Perceived Awareness of the Research Hypothesis Scale questionnaire [ Time Frame: At the end of the study, when all CPT procedures have been carried out, within 10 minutes after the last immersion ]
    Perception of the research hypothesis with the Rubin Questionnaire. Perceived Awareness of the Research Hypothesis " (PARH) wich is a scale of 4-item quantitative self-report method for measuring the potential influence of demand characteristics in research situations
  • Other Outcome Measures: 1. Blood pressure [ Time Frame: About 1 minute before every CPT procedures and within 10 secondes after each CPT procedures ]
    Safety measure to insure blood pressure does not exceed 150/90mmHg (both systolic/diastolic blood pressure, heart rate)
Eligibility Criteria
  • Ages Eligible for Study: 18 to 40 Years (Adult)
  • Sexes Eligible for Study: All
  • Accepts Healthy Volunteers: Yes
Criteria

Inclusion Criteria:

- Person affiliated to Social Security

- Informed consent, written and signed by the subject.

Exclusion Criteria:

- Persons referred to in Articles L1121-5 to L1121-8 of the Public Health Code (CSP),
which corresponds to all protected persons: pregnant women, parturient women, nursing
mothers, persons deprived of their liberty by judicial or administrative decision,
persons subject to a legal protection measure, cannot be included in clinical trials.

- Persons with a pathology against indicating the use of CPT experimentally induced pain
:

- Any pathologies affecting the venous, arterial or lymphatic system

- Diabetes

- Cardiac disorders

- Asthma

- Frostbite

- Epilepsy

- Arthritis

- Lupus erythematosus

- Allergy to Cremafluid® cream

- Person with concomitant treatment that modifies sensitivity to pain, chronic or acute
at the time of the experiment, such as analgesics, psychotropic drugs or
anti-inflammatories.

Contacts and Locations
Contacts

Contact: Nicolas PINSAULT 04 76 76 52 56 npinsault@chu-grenoble.fr

Contact: Carole ROLLAND 04 76 76 69 03 carole.rolland@univ-grenoble-alpes.fr

Locations

France
Leo Druart
Grenoble

France
Saraeve Graham Longsworth
Grenoble

Sponsors and Collaborators

Laboratoire TIMC-IMAG

Investigators

Principal Investigator: Leo DRUART TIMC IMAG Thémas team

Principal Investigator: SaraEve GRAHAM LONGSWORTH TIMC IMAG Thémas team

Study Director: Nicolas PINSAULT TIMC IMAG Thémas team

More Information